🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Transitioning to human-based research will rebuild public trust in science by increasing the reliability and applicability of scientific findings to society #betterscience  #humanrelevant

🚀 New tech doesn’t adopt itself. Microphysiological systems must earn their place by proving: ✅ Human relevance ✅ Clear application ✅ Validation & benchmarking We are committed to these criteria, ensuring Quasi Vivo meets the standards needed for widespread adoption.

Our first jointly hosted scientific #conference alongside Replacing Animal Research and The Humane Research Trust is almost here🙌 26 - 27 March 2025, Radisson Hotel York View the full 2-day agenda and purchase tickets here: humanspecificresearch.org/our-2025-joint… #science #research #nonanimalresearch

Are research tools getting too complex for their own good? MPSs could transform drug discovery, but many are too costly, complex, or specialised for everyday labs. We believe that better science starts with: ✔️ Simpler workflows ✔️ Realistic costs ✔️ Usability first

FDA Modernization Act 2.0 is reshaping drug development. Outdated preclinical models miss human biology, leading to a 90% failure rate in clinical trials. Scalable in-vitro models are our future for smarter, safer therapies.

Dr. Hanna Harrison The University of Manchester is using Quasi Vivo to uncover how breast cancer cells manipulate distant organs to enable metastasis. By studying tumor signaling & niche interactions, her work is bringing us closer to disrupting cancer spread. #CancerResearch #Metastasis

🐾 It’s time to replace animal testing! Join us at the Best Practice in Non-Animal Methods Conference 2025, where Prof. Malcolm Wilkinson will tackle the barriers to human-relevant research. March 26-27 | 📍 York Register now 👉humanspecificresearch.org/our-2025-joint… #HumanRelevantScience

We're delighted to announce sponsors for the upcoming conference: 'Best practice in non-animal research methods', including headline sponsor Bio-Rad Laboratories. 🧪 Jointly hosted w/ Replacing Animal Research and the Centre for Human Specific Research. #BestPracticeInNAMs2025 humaneresearch.org.uk/2025-joint-con…

Predicting drug-induced liver injury is tough & mistakes cost billions. 3D liver models detect 87% of toxic drugs vs. 33–52% for older methods. Quasi-Vivo helps make testing more reliable with longer, human-relevant studies. 🔗 Read more: frontiersin.org/journals/drug-…

AI-driven drug discovery is rapidly generating countless new molecules. Microphysiological systems are essential to quickly and reliably evaluate their safety and effectiveness, accelerating precision medicine and advancing research. pmc.ncbi.nlm.nih.gov/articles/PMC10…

In 2023, nearly 155k live animals were involved in lab incidents that breached UK law. These animals not only suffered experimentation - but inadequate care and often painful deaths. We are calling for a more rigorous enforcement to curtail these horrific violations.

After months of planning, our joint conference on #NAMs with Replacing Animal Research and the Centre for Human Relevant Science is finally here this Wednesday! We hope to inspire scientists and provide the right support so they can pioneer cruelty-free science. humaneresearch.org.uk/2025-joint-con…

Great insights from Prof. Malcolm Wilkinson on the legislative challenges impacting adoption of Microphysiological Systems. Key roadblocks remain, despite progress like FDA Modernization Act 2.0. Much work still ahead! #MPS #AnimalTestingAlternatives

Great to see Eirini Velliou presenting her exciting progress on engineering advanced 3D multicellular models for pancreatic cancer using Kirkstall’s QuasiVivo system.

🧱 Imagine organ-on-a-chip tech as simple as a LEGO kit! Quasi Vivo’s plug‐and‐play, modular design lets you set up advanced 3D cell cultures in minutes. ILow-shear flow keeps tissues thriving, minus the hassle of complex fabrication. Explore more at kirkstall.com

🎯 From liver & brain to tumour microenvironment —Quasi Vivo does it all. Modular circuits 🔁 link multiple organs to realistically study systemic diseases like diabetes right on your benchtop. Healthy tissues, predictive human data, and powerful simplicity in one system.

🎓⚙️Built for Academia & Industry: Academics love the flexibility (run complex 3D cultures without a steep learning curve). Industry loves the consistency (disposable 6-chamber trays for high-content screens​, reproducible results). One platform, tuned for all users.

At today’s The National Centre for the 3Rs showcase, Diana Marcu shared our QV1200 poster: gentle dual-flow perfusion keeps A549 and HEK cells healthier, calmer (↓ IL-6/IL-8) and easy to image—proof that practical, low-shear MPS can drive 3Rs progress without complex microfluidics.

Dr Luigi Margiotta-Casaluci talk drove home a blunt fact: EU tox studies still cost 4.6 M animals (2015-20). No single “eureka” will end that. We need a layered NAM stack—organ-chips, iPSC tissues, high-content imaging and in-silico models—woven into one human-centric safety pipeline.

Great to see strong cross-party support in yesterday’s debate on #HerbiesLaw - time to phase out dog testing (2,456 dogs tested in 2023 alone). At Kirkstall, our Quasi Vivo system helps labs move faster towards animal-free, human-relevant science. Let’s keep up the momentum.